Your browser doesn't support javascript.
loading
Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial.
Inzucchi, Silvio E; Claggett, Brian L; Vaduganathan, Muthiah; Desai, Akshay S; Jhund, Pardeep S; de Boer, Rudolf A; Hernandez, Adrian F; Kosiborod, Mikhail N; Lam, Carolyn S P; Martinez, Felipe; Shah, Sanjiv J; Verma, Subodh; Han, Yaling; Kerr Saraiva, Jose F; Bengtsson, Olof; Petersson, Magnus; Langkilde, Anna Maria; McMurray, John J V; Solomon, Scott D.
Afiliação
  • Inzucchi SE; Section of Endocrinology and Metabolism, Yale School of Medicine, and Yale New Haven Hospital, New Haven, CT, USA. Electronic address: silvio.inzucchi@yale.edu.
  • Claggett BL; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Vaduganathan M; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Desai AS; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Jhund PS; BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
  • de Boer RA; Department of Cardiology, Erasmus Medical Center, Rotterdam, Netherlands.
  • Hernandez AF; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.
  • Kosiborod MN; Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City, Kansas City, MO, USA.
  • Lam CSP; National Heart Centre Singapore and Duke-National University of Singapore, Singapore.
  • Martinez F; Department of Cardiology, University of Cordoba, Cordoba, Argentina.
  • Shah SJ; Bluhm Cardiovascular Institute, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Verma S; Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, Toronto, ON, Canada.
  • Han Y; Cardiovascular Research Institute, Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, China.
  • Kerr Saraiva JF; Clinical Research Institute of Campinas, Sao Paulo, Brazil.
  • Bengtsson O; AstraZeneca, Gothenburg, Sweden.
  • Petersson M; AstraZeneca, Gothenburg, Sweden.
  • Langkilde AM; AstraZeneca, Gothenburg, Sweden.
  • McMurray JJV; BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
  • Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Lancet Diabetes Endocrinol ; 10(12): 869-881, 2022 12.
Article em En | MEDLINE | ID: mdl-36372069
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estado Pré-Diabético / Diabetes Mellitus Tipo 2 / Insuficiência Cardíaca Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Lancet Diabetes Endocrinol Ano de publicação: 2022 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estado Pré-Diabético / Diabetes Mellitus Tipo 2 / Insuficiência Cardíaca Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Lancet Diabetes Endocrinol Ano de publicação: 2022 Tipo de documento: Article País de publicação: Reino Unido